This paper discusses the recent Step 2 document of the International Conference on Harmonization on ethnic factors in the acceptability of foreign clinical data and its possible impact on industry.
LarsonE.Exclusion of certain groups from clinical research. Image—J Nursing Scholar.1994;26(3):185–190.
2.
Draft Consensus Guideline Ethnic Factors in the Acceptability of Foreign Clinical Data, Released for Consultation at Step 2 of the ICH Process on March 6, 1997 by the ICH Steering Committee.
3.
MathewsHWRacial, ethnic and gender differences in response to medicines. Drug Metabol Drug Interact.1995;12(2):77–91.
4.
YasuharaH.Ethnic factors in evaluation of drug efficacy and safety. Folia Pharmacol JPN.1994;104(2): 67–78.
5.
Scrip Daily News. S00420768 of October 20, 1994.
6.
Scrip. No. 2046, July 24, 1995, p. 27.
7.
EdwardsNCImportant considerations in the use of ethnicity as a study variable. Canad J Public Health.1992;83(1):31–33.
8.
BalantLPWellingPGInterethnic factors important for drug development and registration. Clin Res Regul Affairs.1995;12(1):23–46.
9.
CrewsDEBindonJREthnicity as a taxonomic tool in biomedical and biosocial research. Ethnicity Disease.1991;1(1):42–49.
